Various polymorphisms of the X‐chromosomal monoamine oxidase A (MAO‐A) gene were
investigated for association with affective disorders. However, none of the studied variants …

Objectives. Genome-wide association studies (GWAS) in complex phenotypes, including
psychiatric disorders, have yielded many replicated findings, yet individual markers account for …

We carried out a genome-wide association study of schizophrenia (479 cases, 2,937 controls)
and tested loci with P < 10 −5 in up to 16,726 additional subjects. Of 12 loci followed up, 3 …

Bipolar disorders are chronic and recurrent disorders that affect> 1% of the global population.
Bipolar disorders are leading causes of disability in young people as they can lead to …

For more than half a decade, lithium has been successfully used to treat bipolar disorder.
Worldwide, it is considered the first-line mood stabilizer. Apart from its proven antimanic and …

Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of
alleles, including common alleles of small effect that might be detected by genome-wide …

Recurrent microdeletions and microduplications of a 600-kb genomic region of chromosome
16p11.2 have been implicated in childhood-onset developmental disorders 1 , 2 , 3 . We …

Bipolar disorder (BD) is a common and highly heritable mental illness and genome-wide
association studies (GWAS) have robustly identified the first common genetic variants involved …

Background Lithium is a first-line treatment in bipolar disorder, but individual response is
variable. Previous studies have suggested that lithium response is a heritable trait. However, …

Objective The purpose of this study was to identify genetic variants underlying the considerable
individual differences in response to antidepressant treatment. The authors performed a …